Navigation Links
Cipro Has Cheaper Cousins to Treat Anthrax

Cipro, Cipro, Cipro. That's been the mantra of the media as dozens of people exposed to anthrax -- and thousands who weren't -- clamor for the potent antibiotic. But if the supply dwindles, doctors say other cheaper and widely available medications can be used, including a previous generation's wonder drug: penicillin. Although alternatives exist, Cipro is the latest and greatest, so it tends to get attention. //

It helped that Cipro was the only drug approved by the Food and Drug Administration to treat inhaled anthrax. But Health and Human Services Secretary Tommy Thompson today encouraged the use of two other antibiotics, penicillin and doxycycline. Before this month, Cipro -- the brand name for the drug ciprofloxacin -- was little known outside of doctor's offices and pharmacies, where it is dispensed to treat a variety of diseases, including urinary tract infections.

Like other antibiotics, Cipro kills harmful bacteria in the body. The main difference is that it's designed to attack a variety of types of germs. It is effective against a wide range of organisms. Doctors sometimes use Cipro when they are waiting to find out exactly what type of bacteria they're dealing with. It's especially effective against anthrax because it may take days for scientists to discover what kind of strain is involved in an attack.

According to experts, all known strains are vulnerable to Cipro, although the drug must be given before symptoms develop or shortly thereafter to be most effective. Before Cipro came along, penicillin was a common treatment for anthrax. Pharmaceutical companies say they're ready to ramp up production of anti-anthrax drugs if needed.


'"/>




Page: 1

Related medicine news :

1. Once-Daily Cipro(R) XR for Treating Complicated Urinary Tract Infections
2. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
3. Cheaper Vaccines From Tomatoes To Fight HIV, Hepatitis B
4. Diabetics to get Relief from Cheaper Drugs
5. Cheaper and Quicker Alternative to Ovarian Reserve Tests
6. Cousins Recovering from His Substance Abuse Problem
7. Advances in Treatment of Cataracts
8. Recommendations for Treatment of Blood Pressue
9. New FDA Approved Drug To Treat Migraine
10. Treatment for Menieres disease
11. Treatment for pre-menstrual syndrome is ineffective
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... Peoria, IL (PRWEB) , ... May 22, 2017 ... ... HealthCare, is part of a larger group investing in InsightRX, an early stage ... a patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund ...
(Date:5/21/2017)... FL (PRWEB) , ... May 20, 2017 , ... Pot. ... it, find it, review it, and share its attributes like never before. More than ... directory to connect cannabis enthusiasts to stores, strains, products – and for the first ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... longer than six months since you've seen a dentist, it's time for a ... and getting x-rays once per year. , Dental checkups are a relatively easy ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm ... Titled " Ten Good Reasons To Hire An Experienced Personal Injury Attorney, " the ... an accident or injury. As the article says. if someone is injured due ...
(Date:5/19/2017)... ... 19, 2017 , ... As a groundbreaking surgeon on the frontline of prostate ... screenings. Early detection of the disease, he says, can make a world of difference. ... , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate Cancer Task Force and ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: